<DOC>
	<DOCNO>NCT02856165</DOCNO>
	<brief_summary>Over last decade , high-flow nasal oxygen therapy ( HFN ) emerge new method provide respiratory support child moderate severe bronchiolitis . However , randomize clinical trial ( RCT ) demonstrate early support HFN superior standard care include low -flow nasal oxygen therapy reduce risk acute respiratory failure require non invasive ( tracheal ) ventilation subsequently need PICU transfer .</brief_summary>
	<brief_title>High-flow Nasal Oxygen Therapy Hospitalized Infant With Moderate-to-severe Bronchiolitis</brief_title>
	<detailed_description>Open label , non-blinded multi-centre , randomise control trial compare standard care include oxygen delivery via HFN versus standard nasal oxygen therapy infant admit hospital moderate-to-severe bronchiolitis .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<criteria>first episode hospitalise bronchiolitis ( defined American Academy Pediatrics clinical criterion ) age 7 day 6 month transcutaneous SpO2 room air &lt; 95 % modify Wood 's Clinical Asthma Score ( mWCAS ) ≥ 2 et ≤ 5 agreement least one parent legal tutor child participate biomedical research affiliation social security ( beneficiary entitle ) , except beneficiary State medical help Urgent need mechanical ventilation support either nCPAP ou endotracheal route Severe form define modify Wood 's Clinical Asthma Score ( mWCAS ) exceed 5 6 , require non invasive ventilation ( n CPAP ) Uncorrected cyanotic heart disease , innate immune deficiency , craniofacial malformation , congenital stridor , tracheotomy Inclusion observational study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>infant</keyword>
	<keyword>oxygen therapy</keyword>
	<keyword>High flow nasal canula oxygen therapy</keyword>
	<keyword>Bronchiolitis</keyword>
</DOC>